Vigabatrin Ph 1 Cocaine Interaction Study

Completed · Phase 1 · Has a placebo group

Conditions studied: Cocaine Addiction

In brief

This is a Phase 1 safety/tolerably study to determine if there are clinically significant interactions between oral vigabatrin (gamma vinyl-gamma-amino butyric acid; VGB) concurrent with intravenous (IV) cocaine infusions.

Key facts

Study ID

NCT00626834

Run by

National Institute on Drug Abuse (NIDA)

People needed

24

Starts

2008-02-01

Expected to finish

2010-10-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be between 18 and 45 years of age, inclusive
• Currently be a non-treatment seeking cocaine user as confirmed by a positive urine test for cocaine
• Able to provide written informed consent
• A negative pregnancy test within 72 hours prior to receiving the first infusion of cocaine

You may not qualify if…

• Please contact site for more information.

Where it is running

• University of Texas Health Science Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.